Clinical Trial Update: Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab (AVASTIN) with stereotactic body radiotherapy for colorectal liver metastases has completed, exploring radiosensitization a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Dr. Yoo-Joung Ko | Conditions: Colorectal Cancer. | Phase 2 | Status: COMPLETED